コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 trial to evaluate the safety of withholding stress ulcer prophylaxis.
2 parable to proton pump inhibitor therapy for stress ulcer prophylaxis.
3 on histamine-2-antagonists or sucralfate for stress ulcer prophylaxis.
4 savings are associated with more appropriate stress ulcer prophylaxis.
6 as most frequently indicated as a reason for stress ulcer prophylaxis (68.6%), followed by shock/hypo
7 rature to determine the benefit and risks of stress ulcer prophylaxis and the moderating effect of en
8 receptor antagonists, the adverse effects of stress ulcer prophylaxis, and overall cost-effectiveness
9 ng, sucralfate instead of H2-antagonists for stress ulcer prophylaxis, and selective digestive tract
10 nclude prevention of venous thromboembolism, stress ulcer prophylaxis, and semirecumbent positioning
11 r =90%); 3) provide sedation, analgesia, and stress ulcer prophylaxis; and 4) use a 10 g/dL hemoglobi
12 ess ulcer prophylaxis, use of sucralfate for stress ulcer prophylaxis, chlorhexidine oral rinse, sele
13 exidine, venous thromboembolism prophylaxis, stress ulcer prophylaxis, daily spontaneous breathing tr
14 In those patients who were fed enterally, stress ulcer prophylaxis did not alter the risk of gastr
15 ucational intervention regarding appropriate stress ulcer prophylaxis directed at the trauma service.
16 e patients in phase 1 received inappropriate stress ulcer prophylaxis for a drug cost of $2,272.00 (m
17 will review current controversies related to stress ulcer prophylaxis for critically ill adult patien
18 patients were evaluated over 2 months, using stress ulcer prophylaxis guidelines developed by a compr
22 wever, 28.6% of physicians surveyed initiate stress ulcer prophylaxis in all ICU patients, regardless
28 those patients receiving enteral nutrition, stress ulcer prophylaxis may not be required and, indeed
30 rm trauma housestaff on appropriate usage of stress ulcer prophylaxis medications with emphasis on us
31 stics outweighed patient characteristics for stress ulcer prophylaxis (omega, 0.43; 95% CI, 0.34-0.54
32 nfluence of enteral nutrition on the risk of stress ulcer prophylaxis, our findings should be conside
33 eep venous thrombosis prophylaxis (p < .05), stress ulcer prophylaxis (p < .01), oral care for ventil
37 ibe the patients most likely to benefit from stress ulcer prophylaxis, review the comparative efficac
38 frequent event; however, implementation of a stress ulcer prophylaxis risk stratification scheme for
42 ylaxis for deep vein thrombosis (1B); use of stress ulcer prophylaxis to prevent upper gastrointestin
43 ylaxis for deep vein thrombosis (1A); use of stress ulcer prophylaxis to prevent upper gastrointestin
45 on (avoidance of unnecessary antibiotics and stress ulcer prophylaxis, use of sucralfate for stress u
46 ressive drugs to critically ill patients for stress ulcer prophylaxis warrants further evaluation.
47 ase analysis, the expected cost of providing stress ulcer prophylaxis was $6,707 with histamine recep
50 uled intermittent intravenous ranitidine for stress ulcer prophylaxis were enrolled in the study.
52 in patients with acute stress ulcers; thus, stress ulcer prophylaxis with acid-suppressing therapy h
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。